Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVernalis PLC Share News (VER)

  • There is currently no data for VER

Vernalis PLC News

Vernalis losses narrow
12 Apr 2011

Vernalis losses narrow

Strong royalties from its migraine treatment Frovatriptan helped Vernalis narrow losses in the year to 31 December. Pre-tax losses before exceptional...

TechMARK movers: Vodafone falls on SFR rumours
14 Mar 2011

TechMARK movers: Vodafone falls on SFR rumours

Reports that Vivendi will not be willing to pay any more than £6bn for Vodafone's 44% stake in the French mobile phone operator SFR has hit the mobile...

TechMARK movers: Wolfson founder reduces stake
21 Dec 2010

TechMARK movers: Wolfson founder reduces stake

Wolfson Microelectronics is lower after non-executive director and co-founder Dr Alastair Milne raised £725,000 from a share disposal. Dr Milne, who...

TechMARK movers: AEA shares slump on fundraising discount
6 Oct 2010

TechMARK movers: AEA shares slump on fundraising discount

AEA Technology has returned from suspension following the announcement of its deal to acquire Eastern Research Group Inc financed by a heavily discoun...

Small caps: Titon, Utd Drug, Vernalis...
29 Jul 2010

Small caps: Titon, Utd Drug, Vernalis...

Blinds specialist Titon's revenues for the 3 months to June were 19% higher than the corresponding period last year, with UK sales 15% higher and the ...

TechMARK movers: Lack of revenue visibility at Torotrak
29 Jul 2010

TechMARK movers: Lack of revenue visibility at Torotrak

Torotrak has warned that the outcome for the year to March 2011 is still reliant on potential licence discussions and whether Allison transmission tak...

Vernalis 1H Pretax Loss GBP8.91M Vs GBP6.23M
29 Jul 2010

Vernalis 1H Pretax Loss GBP8.91M Vs GBP6.23M

LONDON (Dow Jones)--Vernalis PLC (VER.LN), a development stage pharmaceutical company, said Thursday that it made pretax loss of GBP8.91 million for t...

Biogen's Parkinson's Drug Setback Is Latest Ding In Pipeline
19 Jul 2010

Biogen's Parkinson's Drug Setback Is Latest Ding In Pipeline

By Thomas Gryta Of DOW JONES NEWSWIRES NEW YORK (Dow Jones)--Biogen Idec Inc.'s (BIIB) move to end development of an experimental Parkinson's ...